GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabist Company Holdings Inc (OTCPK:CBSTF) » Definitions » Research & Development

CBSTF (Cannabist Company Holdings) Research & Development : $0.0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Cannabist Company Holdings Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Cannabist Company Holdings's Research & Development for the three months ended in Dec. 2024 was $0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was $0.0 Mil.

Cannabist Company Holdings Research & Development Historical Data

The historical data trend for Cannabist Company Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabist Company Holdings Research & Development Chart

Cannabist Company Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial - - - - -

Cannabist Company Holdings Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Cannabist Company Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cannabist Company Holdings  (OTCPK:CBSTF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Cannabist Company Holdings Research & Development Related Terms

Thank you for viewing the detailed overview of Cannabist Company Holdings's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannabist Company Holdings Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabist Company Holdings Inc (OTCPK:CBSTF) » Definitions » Research & Development
Comparable Companies
TSXV:ROMJ XCNQ:CXXI XCNQ:AYR.A XCNQ:IAN XCNQ:GWAY XCNQ:LEEF TSXV:VM TSX:AVCN XCNQ:EPIC TSXV:DB ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA
Traded in Other Exchanges
VW5:Germany CBST:Canada
Address
680 Fifth Avenue, 24th Floor, New York, NY, USA, 10019
Website
https://cannabistcompany.com
Cannabist Company Holdings Inc is a cultivator, manufacturer, and provider of medical cannabis products and services. Some of its products are Vaporization Oil, Sublingual Tinctures, Lotions, Hard Pressed Tablets, and Suppositories, among others. The company markets its products under ClaraCeed, Seed & Starin, and Triple 777 brands among others.
Executives
David Sirolly officer: Chief Legal Officer/GC C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Julie A Hill director WELLPOINT, INC, 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Jeff Clarke director COMPUTER ASSOCIATES INTERNATIONAL INC, ONE COMPUTER ASSOCIATES PLAZA, ISLANDA NY 11746
Derek Watson officer: Chief Financial Officer C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
David James Hart officer: Chief Operating Officer C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Alison Worthington director C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Bryan Olson officer: Chief People/Admin Officer C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Nicholas Vita director, officer: Chief Executive Officer C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Rosemary Mazanet officer: Chief Scientific Officer 175 TOYOTA PLAZA, 7TH FLOOR, MEMPHIS TN 38103
Guy Hussussian officer: Chief Data Officer C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Jesse Channon officer: Chief Growth Officer C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Michael Abbott director, officer: Chairman C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Philip Goldberg director C/O COLUMBIA CARE INC., 680 FIFTH AVENUE, 24TH FLOOR, NEW YORK NY 10019
Frank Savage director
Kennedy James A C director T ROWE PRICE GROUP INC, 100 E PRATT ST, BALTIMORE MD 21202